Healthcare Global Enterprises Limited

NSE: HCG · Healthcare

₹600.25-1.74%06 Nov 2026

Ask the data

Instant answers about Healthcare Global Enterprises Limited — computed from its filings, no language model

Market cap₹8,962 cr

Current price₹600.25

High / Low₹767 / ₹522

P/E793.1

P/B6.65

Book value₹90.3

ROE0.8%

ROCE9.7%

Debt / equity0.55

Dividend yield—

EPS (TTM)₹0.76

Face value₹10

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

showing latest 6 of 9 periods

	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	831	976	1,096	1,013	1,398	1,694	1,912	2,223	2,545
EBITDA	119	123	172	127	238	299	330	387	466
Operating margin	14.3%	12.6%	15.7%	12.5%	17.0%	17.6%	17.2%	17.4%	18.3%
Interest	42	70	138	119	98	104	109	155	177
Depreciation	71	85	148	159	158	163	174	211	244
Profit before tax	29	-22	-107	-228	89	45	67	56	25
Tax	10	-2	6	-8	49	27	26	8	4
Net profit	21	-25	-107	-193	54	29	48	44	14
EPS ₹	2.38	-2.82	-12.05	-17.02	4.14	2.11	3.46	3.19	0.97
Operating cash flow	—	—	—	—	220	252	285	317	347
Capex	—	—	—	—	71	133	186	209	292
Dividend paid	—	—	—	—	0	0	0	0	0
Total assets	—	—	—	—	—	2,316	2,708	3,543	3,923
Equity	—	—	—	—	—	861	826	922	1,332

Quarterly performance

last 35 quarters · ₹ crore

showing latest 8 of 35 periods

	MAR '18	JUN '18	SEP '18	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	222	227	245	249	257	269	278	278	270	193	248	274	298	323	352	358	365	408	420	425	442	461	487	470	495	526	554	558	585	613	647	633	652	695	732
Operating profit	32	31	34	29	31	45	46	46	36	19	30	38	39	51	62	62	63	72	75	76	76	74	85	79	92	91	102	87	106	108	123	110	125	122	133
Operating margin	14.5%	13.5%	13.7%	11.6%	12.2%	16.7%	16.4%	16.5%	13.3%	10.0%	12.1%	13.8%	13.2%	15.9%	17.5%	17.3%	17.3%	17.7%	17.8%	17.8%	17.3%	16.1%	17.4%	16.7%	18.6%	17.3%	18.5%	15.7%	18.1%	17.6%	19.1%	17.3%	19.2%	17.6%	18.2%
Other income	3	1	2	1	4	1	2	2	2	3	4	6	4	3	3	3	3	3	2	4	5	2	3	6	5	9	11	6	10	7	3	2	13	12	2
Interest	15	18	24	13	16	31	35	36	36	37	27	29	26	26	23	24	24	25	26	27	26	26	27	29	27	34	36	41	44	45	44	45	43	40	38
Depreciation	21	20	21	22	23	34	35	38	42	39	40	42	38	38	38	41	41	40	41	41	42	41	43	44	46	47	50	57	58	58	63	61	63	70	68
Profit before tax	3	-6	-9	-5	-3	-19	-22	-26	-40	-55	-32	-36	-105	-9	144	-46	1	10	10	11	13	10	18	11	28	19	28	-4	14	11	20	-6	1	24	17
Tax	2	-1	-3	-1	3	-2	-2	1	9	-11	-5	-1	9	4	43	4	-1	8	5	7	7	7	7	8	5	5	7	-11	7	6	-1	2	-3	9	9
Net profit	3	-3	-6	-6	-9	-18	-22	-23	-44	-40	-22	-29	-102	-10	103	-46	6	6	7	8	8	8	14	6	21	12	18	7	7	5	16	-9	2	14	5
EPS ₹	0.30	-0.39	-0.74	-0.71	-0.99	-2.05	-2.51	-2.57	-4.91	-4.48	-1.94	-2.33	-8.14	-0.76	8.22	-3.55	0.43	0.44	0.53	0.54	0.60	0.55	0.98	0.41	1.53	0.87	1.29	0.50	0.53	0.34	1.16	-0.68	0.15	0.92	0.32
Revenue YoY	—	—	—	—	15.7%	18.7%	13.5%	11.7%	5.2%	-28.0%	-11.0%	-1.4%	10.2%	67.0%	42.0%	30.7%	22.3%	26.3%	19.3%	18.6%	21.1%	12.9%	15.9%	10.6%	12.0%	14.1%	13.7%	18.7%	18.3%	16.7%	16.9%	13.5%	11.5%	13.4%	13.1%
Profit YoY	—	—	—	—	-436.7%	—	—	—	—	—	—	—	—	—	—	—	—	—	-92.8%	—	39.7%	25.8%	83.9%	-24.4%	154.0%	58.7%	32.6%	22.5%	-65.4%	-60.7%	-9.6%	-235.1%	-70.5%	189.9%	-70.6%

Earlier results (standalone, Mar '16 – Dec '17)

₹ crore · from BSE, before the NSE XBRL filings begin

Healthcare Global Enterprises Limited reports consolidated figures above. Quarterly consolidated results only became mandatory in India in 2019, so the earlier history available is the standalone company only (excluding subsidiaries). It is shown separately so the two bases are never mixed.

Full years

	FY17†
Revenue	539
Operating profit	85
Operating margin	15.8%
Other income	7
Interest	15
Depreciation	43
Profit before tax	35
Tax	12
Net profit	24

Quarters

	MAR '16†	JUN '16†	SEP '16†	DEC '16†	MAR '17†	JUN '17†	SEP '17†	DEC '17†
Revenue	126	134	136	136	133	134	146	142
Operating profit	21	20	21	21	22	18	22	23
Operating margin	16.7%	15.2%	15.7%	15.7%	16.6%	13.6%	15.1%	16.0%
Other income	1	2	2	2	2	2	2	8
Interest	10	3	3	3	4	5	6	7
Depreciation	10	10	11	11	10	10	10	11
Profit before tax	1	8	9	8	9	6	8	14
Tax	-2	3	3	3	3	2	3	5
Net profit	3	6	6	6	6	4	5	9
EPS ₹	0.39	—	—	0.65	0.82	0.45	0.58	1.04
Revenue YoY	—	—	—	—	5.4%	0.1%	7.5%	4.4%
Profit YoY	—	—	—	—	117.5%	-33.0%	-17.5%	61.3%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 32 periods

	DEC '18	MAR '19	JUN '19	SEP '19	DEC '19	MAR '20	JUN '20	SEP '20	DEC '20	MAR '21	JUN '21	SEP '21	DEC '21	MAR '22	JUN '22	SEP '22	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-3.0%	3.1%	3.4%	3.6%	4.3%	4.1%	5.8%	6.4%	6.6%	6.8%	4.8%	4.0%	3.8%	2.1%	1.0%	1.7%	0.8%
ROCE	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	5.8%	10.5%	11.8%	11.8%	11.9%	12.1%	11.7%	12.9%	13.1%	12.9%	10.9%	11.2%	11.7%	11.9%	9.0%	9.3%	9.7%
Net margin	-1.4%	-2.5%	-3.9%	-5.2%	-6.6%	-9.7%	-12.6%	-13.0%	-13.7%	-19.1%	-14.3%	-3.0%	-4.1%	3.8%	4.7%	-1.7%	1.7%	1.7%	1.8%	2.0%	1.9%	2.5%	2.7%	2.8%	2.7%	2.0%	1.6%	1.5%	0.8%	0.5%	0.9%	0.4%
EBITDA margin	13.3%	12.7%	13.6%	14.3%	15.5%	15.7%	14.4%	13.3%	12.5%	12.5%	13.9%	15.2%	16.1%	17.0%	17.5%	17.5%	17.7%	17.6%	17.2%	17.1%	16.9%	17.2%	17.5%	17.8%	17.5%	17.4%	17.5%	17.7%	18.0%	18.3%	18.3%	18.1%
Debt / equity	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.46	0.46	0.46	0.46	0.54	0.54	0.81	0.81	0.87	0.87	1.09	1.09	0.98	0.98	0.68	0.68	0.55
Interest coverage	0.77	0.68	0.57	0.48	0.41	0.22	0.01	-0.12	-0.26	-0.91	-0.69	0.94	0.83	1.91	2.13	0.75	1.32	1.43	1.43	1.50	1.49	1.62	1.65	1.68	1.51	1.36	1.29	1.23	1.22	1.14	1.22	1.22
Asset turnover	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.68	0.71	0.73	0.75	0.75	0.77	0.71	0.73	0.67	0.69	0.63	0.65	0.67	0.69	0.65	0.67	0.73

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 9 periods

	SEP '22	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	139	139	139	139	139	139	141	149	149
Other equity / reserves	742	721	719	686	722	783	780	1,183	1,199
Total equity	881	861	858	826	862	922	921	1,332	1,349
Borrowings	404	399	465	673	750	1,002	904	910	742
Current liabilities	510	570	637	744	835	1,046	1,040	983	870
Non-current liabilities	872	876	921	1,099	1,326	1,507	1,552	1,495	1,425
Total assets	2,272	2,316	2,419	2,708	3,067	3,543	3,586	3,923	3,730
Property, plant & equipment	1,297	1,353	1,414	1,505	1,839	1,963	1,956	2,041	2,166
Capital work-in-progress	64	18	23	83	36	25	96	19	24
Investments	9	10	10	10	11	11	13	14	16
Inventories	37	38	42	43	50	53	62	60	64
Receivables	267	303	333	294	356	401	432	421	486
Cash & equivalents	159	175	118	273	278	236	183	536	120

Cash flow

annual · ₹ crore · line = free cash flow

	FY22	FY23	FY24	FY25	FY26
Cash from operations	220	252	285	317	347
Cash from investing	125	-133	-226	-488	-177
Cash from financing	-155	-140	-64	-42	241
Capex	71	133	186	209	292
Free cash flow	149	118	99	108	55
Dividends paid	0	0	0	0	0

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹2,166 cr58%

CWIP

₹24 cr1%

Investments

₹16 cr0%

Inventories

₹64 cr2%

Receivables

₹486 cr13%

Cash & equivalents

₹120 cr3%

Other assets

₹854 cr23%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Healthcare Global Enterprises Limited	8,962	600.25	793.1	6.65	0.8%

StoxGud checklist: Neutral setup · 4/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month-8.7%

6 months-2.2%

1 year-22.7%

3Y CAGR+17.5%

5Y CAGR+17.5%

10Y CAGR+9.2%

50-day avg₹649.44

200-day avg₹625.19

RSI (14)54

FAQs

What is the share price of Healthcare Global Enterprises Limited?

Healthcare Global Enterprises Limited (HCG) closed at ₹600.25 on NSE on 06 Nov 2026.

What is the market cap of Healthcare Global Enterprises Limited?

₹8,962 crore at the latest close.

What is the P/E ratio of Healthcare Global Enterprises Limited?

793.1, on trailing-twelve-month earnings from its filings.

How fast is Healthcare Global Enterprises Limited growing?

Healthcare Global Enterprises Limited: revenue has compounded at 14.5% a year over three years; net profit at -22.3% a year. Latest-quarter revenue is up 13.1% year on year, profit down 70.6%.

How profitable is Healthcare Global Enterprises Limited?

On a trailing-twelve-month basis return on equity is 0.8%, return on capital employed 9.7%, operating margin 18.1%, net margin 0.4%.

How much debt does Healthcare Global Enterprises Limited have?

Healthcare Global Enterprises Limited is moderately geared: debt to equity is 0.55 with borrowings of ₹742 cr against cash of ₹120 cr (balance sheet of 2026-09-30). Operating profit covers interest 1.2 times.

Financials parsed from Healthcare Global Enterprises Limited's own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from MAR '18, annual from FY18, balance sheet from Sep '22. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.